Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer: S Pyrhönen, T Kuitunen, P Nyandoto & M Kouri.
Naureen StarlingDavid CunninghamPublished in: British journal of cancer (2023)
We discuss Pyrhönen's paper as a catalyst for defining systemic therapy approaches in gastric cancer and how the field has evolved in the last two decades in sequential, targeted and more recently immune-directed therapies and how it may develop to transform survival in this cancer of high unmet need.
Keyphrases
- healthcare
- palliative care
- quality improvement
- clinical trial
- open label
- pain management
- high dose
- study protocol
- randomized controlled trial
- squamous cell carcinoma
- locally advanced
- room temperature
- highly efficient
- reduced graphene oxide
- drug delivery
- gold nanoparticles
- carbon dioxide
- liver metastases
- rectal cancer
- lymph node metastasis
- cell therapy
- visible light